What one share of Spruce Biosciences holds
We are a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need. We have a diverse portfolio of product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are either no approved therapies treating the underlying disease or suboptimal treatment options.
Spruce Biosciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$36.20 |
|---|---|
| Cash and investments | $34.98 |
| Debt | $6.03 |
| Book value | $30.42 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$1,284 | — | — | — | −$3,006 |
| 2020 | — | −$369.78 | $0.93 | −$345.42 | — | — |
| 2021 | — | −$135.78 | $0.30 | −$115.48 | — | $355.56 |
| 2022 | $0.00 | −$147.21 | $0.03 | −$132.90 | — | $217.64 |
| 2023 | $19.65 | −$93.32 | $0.01 | −$64.82 | — | $139.85 |
| 2024 | $8.93 | −$96.40 | $0.00 | −$101.73 | — | $51.19 |
| 2025 | $0.00 | −$50.83 | — | — | — | $30.99 |
Common questions about Spruce Biosciences
How much does one share of Spruce Biosciences earn?
Over the last 12 months, Spruce Biosciences lost $36.20 for each share.
Does Spruce Biosciences pay a dividend?
Spruce Biosciences didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Spruce Biosciences’s book value per share?
Spruce Biosciences’s book value is $30.42 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Spruce Biosciences have?
Each share of Spruce Biosciences has $34.98 of cash and investments and $6.03 of debt, as of June 30, 2026.
Has Spruce Biosciences bought back shares?
Spruce Biosciences’s share count rose about 7421% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.